Memantine Hydrochloride Capsule, Extended Release
Product Images NDC 68180-247

11 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 68180-247). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 01)

Figure 1 (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 01)
Chemical structure of memantine hydrochloride, showing its cage-like adamantane framework with an amine group bonded to hydrochloride.*
FDA Label Image

Figure 2 (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 02)

Figure 2 (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 02)
A line graph showing the mean change from baseline over 24 weeks of treatment in SB Score comparing memantine hydrochloride extended-release 28 mg and placebo, both with AChEI. The graph plots mean (± SEM) change on the vertical axis against weeks of treatment on the horizontal axis, indicating clinical improvement above and clinical decline below the zero baseline.*
FDA Label Image

Figure 3 (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 03)

Figure 3 (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 03)
A cumulative percentage of patients graph showing the SIB (Severe Impairment Battery) change from baseline comparing memantine hydrochloride extended-release 28 mg to placebo. The X-axis represents the SIB change from baseline, and the Y-axis shows the cumulative percentage of patients, with two lines representing memantine HCl extended-release and placebo groups.*
FDA Label Image

Figure 4 (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 04)

Figure 4 (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 04)
A line graph depicting the mean (± SEM) change in CIBIC-Plus Scores over 24 weeks of treatment, comparing Memantine HCl Extended-Release 28 mg/AChEI with a placebo/AChEI. The graph shows clinical improvement and decline regions, with the Memantine group maintaining higher scores than the placebo group during the study period.*
FDA Label Image

Figure 5 (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 05)

Figure 5 (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 05)
A bar chart comparing patient outcomes based on the CIBIC Plus Rating for Memantine HCl Extended-Release 28 mg/AChEI versus Placebo/AChEI. The y-axis shows the percentage of patients, while the x-axis lists categories from marked improvement to marked worsening. The chart displays relative frequencies of these outcomes for each treatment group.*
FDA Label Image

Image (E7dc37e2 B1d1 4abf 89a4 6cffd5392597 124 1)

Image (E7dc37e2 B1d1 4abf 89a4 6cffd5392597 124 1)
The image is an anatomical illustration showing a side view of the human spine composed of vertebrae with a spinal column representation. The diagram highlights the spinal structure and is likely intended for educational or instructional purposes related to the spine or back.*
FDA Label Image

Image (E7dc37e2 B1d1 4abf 89a4 6cffd5392597 196 1)

Image (E7dc37e2 B1d1 4abf 89a4 6cffd5392597 196 1)
An anatomical illustration depicting the human spine and pelvis viewed from the rear. The spine is shown as a series of vertebrae stacked vertically with the pelvis at the base. No text or labels are visible in the image.*
FDA Label Image

7mg (30s Bottle)

7mg (30s Bottle)
Label for Memantine Hydrochloride Extended-release Capsules 7 mg by Lupin Pharmaceuticals, Inc. The label indicates a 30-capsule package and includes storage instructions, barcode, and manufacturing information, including Lupin Limited in India as the manufacturer.*
FDA Label Image

14 mg- 30s Bottle (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 07)

14 mg- 30s Bottle (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 07)
Label for Memantine Hydrochloride Extended-release Capsules 14 mg by Lupin Pharmaceuticals, Inc. The label states the product is once-daily, contains 30 capsules, and is for prescription use only. It includes storage instructions, manufacturer details (Lupin Limited, India), and a barcode. The label shows the strength prominently along with the NDC 68180-247-06.*
FDA Label Image

21 mg-30s Bottle (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 08)

21 mg-30s Bottle (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 08)
Label for Memantine Hydrochloride Extended-release Capsules 21 mg by Lupin Pharmaceuticals, Inc. The label indicates 30 capsules, with storage instructions and manufacturer information for Lupin Pharmaceuticals, Inc., Naples, FL, and Lupin Limited, India. It is for prescription use and specifies the NDC 68180-248-06.*
FDA Label Image

28 mg (30s Bottle)

28 mg (30s Bottle)
Label for Memantine Hydrochloride Extended-release Capsules 28 mg, containing 30 capsules per container. The label shows the product is manufactured for Lupin Pharmaceuticals, Inc. and made by Lupin Limited in India. It includes dosage form, strength, NDC 68180-249-06, storage instructions, and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.